Gert Attard
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Attributes and Health Care Resource Utilization of Patients on Enzalutamide or Abiraterone for Metastatic Castration-Resistant Cancer in England.
Journal: JCO oncology practice
Published: April 21, 2025
Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial.
Journal: European urology oncology
Published: January 13, 2025
Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography.
Journal: European urology oncology
Published: August 29, 2022
The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer.
Journal: Frontiers in artificial intelligence
Published: September 02, 2021
Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK - A16037).
Journal: Therapeutic advances in medical oncology
Published: May 14, 2020
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.
Journal: Trials
Published: August 10, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026